Onco360

Tesaro, now a part of GSK, is dedicated to providing groundbreaking therapies for cancer patients. Their focus remains on delivering transformational treatments that make a difference in the lives of those affected by cancer. With a commitment to innovation and patient care, Tesaro at GSK is at the forefront of developing new and effective solutions to combat cancer. Their mission is to improve outcomes and bring hope to individuals battling this disease. Generated from their website's infomation

Cugene Corp is a clinical-stage biotechnology company based in Waltham, MA, specializing in the development of precision immunology and oncology medicines. Their innovative approach involves leveraging specific immune cells to treat autoimmune diseases and cancer, using precision molecular engineering and molecular modeling to create novel molecules with highly selective immune stimulatory capacities. With a focus on efficacy, safety, and synergy, Cugene designs molecules with superior pharmacokinetics, target cell specificity, and tumor-killing capabilities, while minimizing unwanted side effects. Their cutting-edge biotech advancements aim to address unmet medical needs in autoimmune disease and oncology, attracting top talent through a collaborative culture and offering benefits such as medical, dental, vision, and work-life balance.Generated from the website

Novobiotic Pharmaceuticals is a biotechnology company located in Cambridge, Massachusetts, specializing in the development of innovative pharmaceutical solutions. The company focuses on harnessing the potential of natural products, particularly from microbial sources, to address unmet medical needs. With a dedicated team of scientists and researchers, Novobiotic Pharmaceuticals is committed to advancing the field of drug discovery and development. Their work emphasizes the importance of scientific research in creating effective therapies for various health challenges. Generated from the website